20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)
出版年份 2020 全文链接
标题
20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)
作者
关键词
-
出版物
World Psychiatry
Volume 19, Issue 1, Pages 61-68
出版商
Wiley
发表日期
2020-01-11
DOI
10.1002/wps.20699
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antipsychotic use and risk of life‐threatening medical events: umbrella review of observational studies
- (2019) D. Papola et al. ACTA PSYCHIATRICA SCANDINAVICA
- Mortality in schizophrenia: 30-year nationwide follow-up study
- (2018) A. Tanskanen et al. ACTA PSYCHIATRICA SCANDINAVICA
- Clozapine reduces nicotine self-administration, blunts reinstatement of nicotine-seeking but increases responding for food
- (2018) Andrew R. Abela et al. ADDICTION BIOLOGY
- 20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia
- (2018) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- The effect of multifactorial lifestyle interventions on cardiovascular risk factors: a systematic review and meta-analysis of trials conducted in the general population and high risk groups
- (2018) L.G. Sisti et al. PREVENTIVE MEDICINE
- Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1–12.5 Years
- (2018) Jentien M Vermeulen et al. SCHIZOPHRENIA BULLETIN
- What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?
- (2018) Christoph U. Correll et al. World Psychiatry
- Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review
- (2018) Jessica W. Y. Yuen et al. Frontiers in Neuroscience
- EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH)
- (2018) Brendon Stubbs et al. EUROPEAN PSYCHIATRY
- Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis
- (2018) Maren Carbon et al. World Psychiatry
- Mortality and the relationship of somatic comorbidities to mortality in schizophrenia. A nationwide matched-cohort study
- (2017) I. Bitter et al. EUROPEAN PSYCHIATRY
- Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis
- (2017) J. Vermeulen et al. PSYCHOLOGICAL MEDICINE
- Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia—A Nationwide Study With 20-Year Follow-up
- (2017) Heidi Taipale et al. SCHIZOPHRENIA BULLETIN
- Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls
- (2017) Christoph U. Correll et al. World Psychiatry
- Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis
- (2017) Davy Vancampfort et al. World Psychiatry
- Drug exposure in register-based research—An expert-opinion based evaluation of methods
- (2017) Antti Tanskanen et al. PLoS One
- Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia
- (2017) Heidi Taipale et al. SCHIZOPHRENIA RESEARCH
- Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study
- (2016) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis
- (2016) Davy Vancampfort et al. World Psychiatry
- Suicide in the Early Stage of Schizophrenia
- (2016) Antonio Ventriglio et al. Frontiers in Psychiatry
- From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)
- (2015) Antti Tanskanen et al. BMC Medical Informatics and Decision Making
- Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
- (2015) Christoph U. Correll et al. World Psychiatry
- Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis
- (2015) Davy Vancampfort et al. World Psychiatry
- Comorbidities and Mortality in Persons With Schizophrenia: A Swedish National Cohort Study
- (2013) Casey Crump et al. AMERICAN JOURNAL OF PSYCHIATRY
- Comparative Mortality Risk in Adult Patients With Schizophrenia, Depression, Bipolar Disorder, Anxiety Disorders, and Attention-Deficit/Hyperactivity Disorder Participating in Psychopharmacology Clinical Trials
- (2013) Arif Khan et al. JAMA Psychiatry
- Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
- (2012) Stefan Leucht et al. LANCET
- Medication for Attention Deficit–Hyperactivity Disorder and Criminality
- (2012) Paul Lichtenstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia
- (2012) M. Lahti et al. PSYCHOLOGICAL MEDICINE
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices
- (2011) A. J. Mitchell et al. PSYCHOLOGICAL MEDICINE
- Metabolic Testing Rates in 3 State Medicaid Programs After FDA Warnings and ADA/APA Recommendations for Second-Generation Antipsychotic Drugs
- (2010) Elaine H. Morrato et al. ARCHIVES OF GENERAL PSYCHIATRY
- Findings of a U.S. National Cardiometabolic Screening Program Among 10,084 Psychiatric Outpatients
- (2010) Christoph Correll PSYCHIATRIC SERVICES
- Second-Generation Antipsychotic Drugs and Extrapyramidal Side Effects: A Systematic Review and Meta-analysis of Head-to-Head Comparisons
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA BULLETIN
- 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
- (2009) Jari Tiihonen et al. LANCET
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
- (2009) Wayne A. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started